NCT00216541View on ClinicalTrials.gov

A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy

PHASE4CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

September 30, 2006

Conditions

AnemiaNeoplasms

Interventions

DRUG

epoetin alfa

All Listed Sponsors

lead

Janssen-Cilag B.V.

INDUSTRY

NCT00216541 - A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy | Biotech Hunter | Biotech Hunter